Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Autonomic Nervous System01:22

Autonomic Nervous System

The autonomic nervous system (ANS) is a critical component of the peripheral nervous system, primarily responsible for regulating involuntary bodily functions and maintaining homeostasis. It functions in tandem with the central nervous system (CNS) to seamlessly coordinate various physiological processes without the need for conscious control.
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
Autonomic Nervous System: Overview01:26

Autonomic Nervous System: Overview

The human nervous system is divided into two main parts: the central nervous system (CNS) and the peripheral nervous system (PNS). The CNS is composed of the brain and spinal cord, while the PNS contains nerve cells, clusters of nerve cells, and the sensory receptors that are outside the CNS. The PNS has two types of nerve cells: sensory (afferent) and motor (efferent). Sensory cells send signals to the CNS from receptors, and motor cells carry signals from the CNS to organs, muscles, and...
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term treatment outcomes of immune checkpoint inhibitor-related neuropathies: a French multicenter cohort study.

Scientific reports·2026
Same author

Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extension.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2026
Same author

Clinical Features and Prognosis of SEPTIN9-Related Hereditary Neuralgic Amyotrophy.

European journal of neurology·2026
Same author

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

medRxiv : the preprint server for health sciences·2026
Same author

Effect of Eplontersen in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy Across Genetic Variants: An Exploratory Analysis From the NEURO-TTRansform Trial.

European journal of neurology·2026
Same author

Reflexivity and Change in Adaptive Physical Activity.

Adapted physical activity quarterly : APAQ·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
Same journal

Beyond one-size-fits-all: Personalising health communication to drive real behaviour change.

Presse medicale (Paris, France : 1983)·2026
Same journal

Metacognition and post-decisional processing in clinical decision-making.

Presse medicale (Paris, France : 1983)·2026
Same journal

Fast-and-frugal decision trees for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Related Experiment Video

Updated: May 18, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

[Autonomic peripheral neuropathy].

David Adams1, Cecile Cauquil, Pierre Lozeron

  • 1AP-HP, CHU de Bicêtre, service de neurologie, 94275 Le Kremlin-Bicêtre cedex, France. david.adams@bct.aphp.fr

Presse Medicale (Paris, France : 1983)
|October 2, 2012
PubMed
Summary
This summary is machine-generated.

Dysautonomia, or autonomic nervous system dysfunction, has varied causes, often linked to peripheral neuropathies like diabetes. Early diagnosis and symptomatic treatment are crucial for managing this condition and improving patient quality of life.

Related Experiment Videos

Last Updated: May 18, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

Area of Science:

  • Neurology
  • Autonomic Nervous System Research
  • Peripheral Neuropathy Studies

Background:

  • Dysautonomic disturbances are primarily acquired, stemming from damage to sympathetic or parasympathetic nerve fibers or ganglia.
  • Peripheral neuropathies, both chronic and acute, are frequently associated with dysautonomia.
  • While many causes exist, diabetic dysautonomia is the most prevalent globally, significantly impacting cardiovascular health and survival.

Purpose of the Study:

  • To review the diverse mechanisms and causes of dysautonomic disturbances.
  • To highlight the clinical significance of identifying specific causes of dysautonomia.
  • To discuss diagnostic approaches and treatment strategies for autonomic neuropathies.

Main Methods:

  • Review of existing literature on dysautonomia and peripheral neuropathies.
  • Analysis of etiological factors, including acquired and hereditary conditions.
  • Discussion of diagnostic confirmation methods, such as molecular biology.
  • Examination of treatment implications, focusing on symptomatic relief and causal therapies.

Main Results:

  • Dysautonomia mechanisms are varied, involving lesions in peripheral nerve fibers, ganglia, demyelination, or axonal loss.
  • Diabetes is the leading cause of dysautonomia worldwide, with severe cardiovascular dysfunction affecting prognosis.
  • Rare hereditary forms, like Riley-Day syndrome and transthyretin amyloid polyneuropathies, exist and can be diagnosed via molecular biology.

Conclusions:

  • Dysautonomia is a frequent and often severe complication of peripheral neuropathies.
  • Identifying the underlying cause is critical for clinical management and potential disease modification.
  • Symptomatic treatments are essential for improving quality of life, while specific therapies can target causal factors to halt disease progression.